Feature Channels:

Alzheimer's and Dementia

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Parkinson Disease Treatment

For Some, Smell Test May Signal Parkinson’s Disease up to 10 Years Before Diagnosis

A simple scratch-and-sniff test may one day be able to help identify some people at greater risk of developing Parkinson’s disease up to 10 years before the disease could be diagnosed, according to a new study published in the September 6, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Medicine

Channels:

Alzheimers disease, Neurobiology, Neuroscience

Unraveling Alzheimer’s: New Study Documents How Brain Cells Go Bad

COHEN_calciumincrease_neurons_ONESLIDEONLY.jpg

Scientists have known that abnormal protein deposits and swarms of activated immune cells accumulate in brains of people with Alzheimer’s. Now researchers have untangled how these proteins and inflammation interact in lab experiments to reveal how therapies might reverse the disease process.

Medicine

Channels:

Undergraduates, Bioengineering, Alzheimer's Disease, Brain Surgery, tb diagnosis

Disease Diagnostics Take Top Honors of DEBUT Biomedical Engineering Design Competition

EEG.jpg

Tools to diagnose Alzheimer’s disease and latent tuberculosis are among the winning projects in the Design by Biomedical Undergraduate Teams (DEBUT) challenge, a biomedical engineering design prize competition for teams of undergraduate students. The teams developed prototypes of devices that advance technology and improve human health.

Medicine

Channels:

Alzheimer's, exercise, cognitive fitness, Dementia, cognitive fitness, Exercise

Physical Activity in Midlife Not Linked to Cognitive Fitness in Later Years, Long-Term Study Suggests

A study led by Johns Hopkins Bloomberg School of Public Health researchers that tracked activity levels of 646 adults over 30 years found that, contrary to previous research, exercise in mid-life was not linked to cognitive fitness in later years.

Medicine

Channels:

Cell Cycle, retinoblastoma gene, Alzheimer, Degenerative Disease, neuron death, Antonio Giordano, Sbarro Health Research Organization, temple univeristy, Tumor Suppressor Genes, Rb2/P130

Targeting Cell Cycle Reactivation Caused by Inflammation May Provide the Way to Prevent Neuron Death in Alzheimer’s Disease

confocalfuorescencemicroscopyofneurons.jpg

Researchers have discovered a clue to the mechanism for neuronal degeneration and possible target for a therapeutic approach to these disorders.

Medicine

Channels:

Dementia, Sleep Disorder

Less REM Sleep Tied to Greater Risk of Dementia

People who get less rapid eye movement (REM) sleep may have a greater risk of developing dementia, according to a new study published in the August 23, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology. REM sleep is the sleep stage when dreaming occurs.

Medicine

Channels:

Alzheimer, Alzheimer's Disease, alzheimers, NeuroVision, retinal imaging, noninvasive eye scans, Keith Black, Maya Koronyo-Hamaoui, Beta-amyloid Plaque

Clinical Study Shows That Retinal Imaging May Detect Signs of Alzheimer’s Disease

JCI_Insight_Image1.jpg

A study led by researchers at Cedars-Sinai and NeuroVision Imaging LLC provides the scientific basis for using noninvasive eye imaging to detect the pathological hallmarks of Alzheimer’s. The experimental technology, developed by Cedars-Sinai and NeuroVision, scans the retina using techniques that can identify beta-amyloid protein deposits that mirror those in the brain.

Medicine

Channels:

Alzheimer, Alzheimer's, Alzheimer's Disease, Alzheimers disease, alzheimers, Keith Black, Maya Koronyo, NeuroVision, retinal imagin, eye scan

Noninvasive Eye Scan Could Detect Key Signs of Alzheimer’s Disease Years Before Patients Show Symptoms

JCI-Insight-Retinal-Imaging-08-17-17.jpg

Cedars-Sinai neuroscience investigators have found that Alzheimer’s disease affects the retina – the back of the eye – similarly to the way it affects the brain. The study also revealed that an investigational, noninvasive eye scan could detect the key signs of Alzheimer’s disease years before patients experience symptoms.

Medicine

Channels:

St. Jude Children's Research Hospital, J. Paul Taylor, Neuron, ALS, Lou Gehrig's Disease, , frontotemporal dementia , Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, phase separation, ALS treatment

Researchers Discover Fundamental Pathology Behind ALS

00177033-011.jpg

A team led by scientists at St. Jude Children’s Research Hospital and Mayo Clinic has identified a basic biological mechanism that kills neurons in amyotrophic lateral sclerosis (ALS) and in a related genetic disorder, frontotemporal dementia (FTD), found in some ALS patients. ALS is popularly known as Lou Gehrig’s disease. The researchers were led by J. Paul Taylor, M.D., Ph.D., chair of the St. Jude Cell and Molecular Biology Department and a Howard Hughes Medical Institute investigator; and Rosa Rademakers, Ph.D., of the Mayo Clinic in Jacksonville, Florida. The findings appear today in the journal Neuron.

Medicine

Channels:

Nursing Home, Nursing Home Care, Dementia, Alzheimber's Disease, Nursing

Improving Nursing Home Care for People with Dementia

Olga_Jarrin_Hi.JPG

Rutgers and Duke University professors explore how to improve care and reduce the use of antipsychotic medications in nursing homes







Chat now!